Head to Head Survey: Sharps Technology (NASDAQ:STSS) & OrthoPediatrics (NASDAQ:KIDS)

Sharps Technology (NASDAQ:STSS) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk.

Profitability

This table compares Sharps Technology and OrthoPediatrics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sharps Technology	N/A	-100.69%	-71.53%
OrthoPediatrics	-14.35%	-5.44%	-4.67%

Valuation & Earnings

This table compares Sharps Technology and OrthoPediatrics”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sharps Technology	N/A	N/A	-$9.84 million	($0.60)	-0.26
OrthoPediatrics	$175.07 million	3.35	-$20.97 million	($0.96)	-25.64

Sharps Technology has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Sharps Technology, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

17.2% of Sharps Technology shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 12.6% of Sharps Technology shares are held by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Volatility and Risk

Sharps Technology has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Sharps Technology and OrthoPediatrics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sharps Technology	0	0	0	0	N/A
OrthoPediatrics	0	1	2	0	2.67

OrthoPediatrics has a consensus target price of $42.00, indicating a potential upside of 70.66%. Given OrthoPediatrics’ higher possible upside, analysts clearly believe OrthoPediatrics is more favorable than Sharps Technology.

Summary

OrthoPediatrics beats Sharps Technology on 7 of the 11 factors compared between the two stocks.

About Sharps Technology

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.